News
Life Sciences M&A Values Soar in 2011 May 14, 2012 | Press Release
Life Sciences M&A Activity Heats Up in April, says Burrill & Company May 01, 2012 | Press Release
Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health April 16, 2012 | Press Release
See all News
Stephen A. Hurly
CEO, Burrill Merchant Banking and Head of Investment BankingStephen A. Hurly joined Burrill Merchant Banking as its CEO and head of investment banking in June 2011. He brings an expertise in assisting public and private firms with strategic transactions, difficult financings, product licensing, joint ventures and restructurings. He has experience at both bulge bracket firms as well as specialized boutiques. Through extensive industry relationships and global transaction experience in China, Japan, Australia, the European Union and North America, Mr. Hurly and his team provide tailored solutions and insight to assist clients in reaching their strategic goals.
Mr. Hurly was previously with Boenning & Scattergood Inc., as a Managing Director and Global Head of the firm's Health Care Investment Banking Practice. Prior to that appointment, Mr. Hurly was the Managing Director and Head of the Life Sciences Group at Janney Montgomery Scott. His earlier investment banking experience was with Hambrecht & Quist in San Francisco, where he closed over 30 public and private financings as well as M&A transactions, eventually becoming a member of the executive offices.
Mr. Hurly is an expert in strategic transactions and associated capital raising, and has completed over 100 deals with an aggregate value over $10 billion and over $400 million in capital. He has an M.B.A. from the University of Chicago and a B.S. in Engineering from Swarthmore College.


